Theranostics and PET Imaging Diagnostics

Get insights from experts in the field who shared their insights on the use of PET imaging in theranostics to improve outcomes for men suffering from prostate cancer.

This webinar is already ready over. Missed the live webinar or want to rewatch it?

Speakers

Dr Lisa Bodei, PhD

MD, Director of Targeted Radionuclide Therapy, Molecular Imaging and Therapy Service, Department of Radiology

Memorial Sloan Kettering Cancer Center, US
Prof Michael Hofman

Nuclear Medicine Physician

Peter MacCallum Center, Melbourne, Australia
Topics
- Use of PET Imaging companion radiopharmaceutical in theranostics
- Evolving evidence-base for PSMA Theranostics to improve outcomes for men with prostate cancer